Federated Hermes heads into its Q1 2026 earnings release today carrying the sharpest weekly build in short interest it has seen in months — a notable shift in positioning just as the market wants clarity on money market fund flows and AUM trajectory.
The short interest story is the most striking data point this week. Bearish positioning jumped nearly 16% over the past five days, with SI % of Free Float climbing to 4.3% of the float from roughly 2.7% just two weeks ago. The move started mid-April and accelerated into the print: from April 22 through April 24, shorts added more than 400,000 shares in two sessions. Days to cover is running at around four days, giving any reversal meaningful friction. Despite that build, the borrow market remains relaxed — cost to borrow is a negligible 0.44%, and availability is ample, meaning this positioning reflects genuine conviction rather than a technically forced setup. There is no squeeze pressure in the lending pool.
Options positioning reinforces the bullish lean from the options desk, creating a deliberate contrast with the short sellers. The put/call ratio has collapsed to 0.21, nearly 1.6 standard deviations below its 20-day mean of 0.28. Call demand is running well ahead of puts — the lowest PCR reading of this period sits near 0.21, far from the 52-week defensive extreme of 1.31. The RSI at 51 is neutral, leaving the technical setup unresolved ahead of the catalyst.
The Street's overall posture is cautious but not hostile. JP Morgan's Kenneth Worthington downgraded FHI to Underweight on April 16 — the most recent and consequential analyst action — while simultaneously nudging the price target one dollar higher to $56. The stock closed at $56.36 on April 29, meaning the JP Morgan target sits fractionally below current levels. RBC Capital and TD Cowen have both been incrementally raising targets in small steps, landing at $55 and $54 respectively, with neither moving off neutral or hold stances. Evercore has maintained an Outperform with a $55 target. In aggregate, the mean analyst target is $57, implying less than 1% upside from here. With a P/E of around 10x, an EV/EBITDA near 6.8x, and an earnings yield approaching 10%, the valuation is undemanding. The dividend score ranks at the 92nd percentile — income investors find the yield attractive even as growth sceptics focus on the bear case.
The bull and bear debate around FHI has a familiar structure for asset managers. Bulls point to $871 billion in AUM as of September 2025, with cash management — about 53% of revenue — benefiting from institutional demand for money market funds in a higher-for-longer rate environment. Bears counter with long-term net outflows of $466 million, fixed-income weakness, and structural headwinds from passive investing eroding active AUM over time. The EPS surprise factor ranks at the 76th percentile, suggesting the company has a recent history of beating consensus — that may be what the call-heavy options market is pricing ahead of tonight's print.
Inside the shareholder base, recent activity has been one-sided. CFO Thomas Donahue sold 30,000 shares at $57.10 on March 13 for just over $1.7 million — a meaningful disposal at the top end of the recent trading range. VP Paul Uhlman sold more than 72,000 shares across two transactions on March 12 for roughly $4.1 million combined. The 90-day net across all insiders is a net sale of approximately $8 million in value, with no purchases recorded in the window. Insiders have been consistent sellers near and above current price levels.
What to watch tonight is less about the headline EPS number and more about net flows in long-term strategies and any guidance on fee rate pressure from money market funds if rate expectations shift. The pace at which shorts rebuilt into this print — almost entirely in the final two weeks of April — makes the direction of the initial reaction a meaningful test of whether that positioning was prescient or premature.
See the live data behind this article on ORTEX.
Open FHI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
